Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 11, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesFeb 10, 2015View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 9, 2015View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 9, 2015View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 6, 2015View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 4, 2015View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 3, 2015View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 2, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingFeb 2, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC TO-T/AAmendment to a previously filed SC TO-TJan 30, 2015View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 30, 2015View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Jan 28, 2015View HTMLDownload DOCDownload PDF
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%Jan 26, 2015View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 23, 2015View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Jan 22, 2015View HTMLDownload DOCDownload PDFDownload XLS
EFFECTNotice from the SEC of registration effectivenessJan 21, 2015View HTMLDownload DOCDownload PDF
POS AMPost-effective amendment to an S-Type filingJan 21, 2015View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Jan 21, 2015View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 16, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC TO-T/AAmendment to a previously filed SC TO-TJan 15, 2015View HTMLDownload DOCDownload PDFDownload XLS
S-8Securities offered to employees pursuant to employee benefit plansJan 14, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC TO-T/AAmendment to a previously filed SC TO-TJan 13, 2015View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-127

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information